FLGT
Closed
Fulgent Genetics Inc
19.91
+0.03 (+0.15%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 19.88
Day's Range: 19.75 - 20.37
Send
sign up or login to leave a comment!
When Written:
30.815
Fulgent Genetics Inc. is a publicly traded company based in California, USA. It was founded in 2011 and provides genetic testing and analysis services to healthcare providers and patients. The company offers a wide range of genetic tests for various diseases, including cancer, cardiovascular diseases, neurological disorders, and rare genetic diseases.
Fulgent Genetics uses advanced technology and data analytics to provide accurate and reliable results to its clients. The company's proprietary technology platform, called Fulgent's Focus, allows it to analyze large amounts of genetic data quickly and efficiently. This platform also enables the company to customize its testing services to meet the specific needs of its clients.
Fulgent Genetics has partnerships with several healthcare providers, including hospitals, clinics, and research institutions. The company's testing services are used by healthcare providers to diagnose and treat patients, as well as to conduct research into genetic diseases.
As of 2021, Fulgent Genetics has a market capitalization of over $4 billion and employs over 1,000 people. The company has been recognized for its innovative technology and has received several awards for its services, including the 2020 Frost & Sullivan Best Practices Award for Growth Excellence.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Fulgent Genetics uses advanced technology and data analytics to provide accurate and reliable results to its clients. The company's proprietary technology platform, called Fulgent's Focus, allows it to analyze large amounts of genetic data quickly and efficiently. This platform also enables the company to customize its testing services to meet the specific needs of its clients.
Fulgent Genetics has partnerships with several healthcare providers, including hospitals, clinics, and research institutions. The company's testing services are used by healthcare providers to diagnose and treat patients, as well as to conduct research into genetic diseases.
As of 2021, Fulgent Genetics has a market capitalization of over $4 billion and employs over 1,000 people. The company has been recognized for its innovative technology and has received several awards for its services, including the 2020 Frost & Sullivan Best Practices Award for Growth Excellence.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








